85 related articles for article (PubMed ID: 6693772)
1. Cytolysis of nucleated cells by complement: inhibition of membrane-transmethylation enhances cell death by C5b-9.
Hänsch GM; Betz M; Shin ML
J Immunol; 1984 Mar; 132(3):1440-4. PubMed ID: 6693772
[TBL] [Abstract][Full Text] [Related]
2. Nucleated cell killing by complement: effects of C5b-9 channel size and extracellular Ca2+ on the lytic process.
Kim SH; Carney DF; Hammer CH; Shin ML
J Immunol; 1987 Mar; 138(5):1530-6. PubMed ID: 2433349
[TBL] [Abstract][Full Text] [Related]
3. Elimination of terminal complement intermediates from the plasma membrane of nucleated cells: the rate of disappearance differs for cells carrying C5b-7 or C5b-8 or a mixture of C5b-8 with a limited number of C5b-9.
Carney DF; Koski CL; Shin ML
J Immunol; 1985 Mar; 134(3):1804-9. PubMed ID: 3968432
[TBL] [Abstract][Full Text] [Related]
4. Humoral immune killing of nucleated cells: mechanisms of complement-mediated attack and target cell defense.
Ohanian SH; Schlager SI
Crit Rev Immunol; 1981 Jan; 1(3):165-209. PubMed ID: 6174273
[TBL] [Abstract][Full Text] [Related]
5. Complement-mediated inhibition of function in complement-resistant Escherichia coli.
Dankert JR
J Immunol; 1989 Mar; 142(5):1591-5. PubMed ID: 2645364
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of membrane lipid metabolism enhance complement-mediated nucleated cell killing through distinct mechanisms.
Papadimitriou JC; Carney DF; Shin ML
Mol Immunol; 1991 Aug; 28(8):803-9. PubMed ID: 1875952
[TBL] [Abstract][Full Text] [Related]
7. Plasma membrane and intracellular lipid synthesis in tumor cells rendered resistant to humoral immune killing after treatment with hormones.
Schlager SI; Ohanian SH
J Natl Cancer Inst; 1980 Apr; 64(4):943-50. PubMed ID: 6988626
[TBL] [Abstract][Full Text] [Related]
8. The deposition of C5b-9 complexes and its precursors on E. coli J5 during complement activation enhances uptake and toxicities of gentamicin.
Bloch EF; Morrison K; McDonald-Pinkett S; Baskin S; Campbell S; Peters S; Dillahunt S; Evans D; Lucas S; Macatangay A; Kanaan Y
Immunol Invest; 2008; 37(3):245-61. PubMed ID: 18389443
[TBL] [Abstract][Full Text] [Related]
9. Sublytic complement attack exposes C-reactive protein binding sites on cell membranes.
Li YP; Mold C; Du Clos TW
J Immunol; 1994 Mar; 152(6):2995-3005. PubMed ID: 8144898
[TBL] [Abstract][Full Text] [Related]
10. Involvement of the c-jun N-terminal kinases JNK1 and JNK2 in complement-mediated cell death.
Gancz D; Donin N; Fishelson Z
Mol Immunol; 2009 Dec; 47(2-3):310-7. PubMed ID: 19864026
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulators and the complement system.
Kondo M; Kato H; Yoshikawa T; Sugino S
Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):67-72. PubMed ID: 3713376
[TBL] [Abstract][Full Text] [Related]
13. Complement. Historical perspectives and some current issues.
Mayer MM
Complement; 1984; 1(1):2-26. PubMed ID: 6100484
[No Abstract] [Full Text] [Related]
14. Beyond lysis: how complement influences cell fate.
Cole DS; Morgan BP
Clin Sci (Lond); 2003 May; 104(5):455-66. PubMed ID: 12580763
[TBL] [Abstract][Full Text] [Related]
15. [Complement and biological membrane].
Takahashi M
Nihon Rinsho; 1979; 37(7):2782-91. PubMed ID: 393861
[No Abstract] [Full Text] [Related]
16. Mechanism of enhanced complement-dependent cytotoxicity of papain-treated lymphocytes: evidence for increased stability of classical pathway C3 convertase.
Lublin DM; Grumet FC
J Immunol; 1982 Feb; 128(2):866-70. PubMed ID: 6915075
[TBL] [Abstract][Full Text] [Related]
17. Antibody-mediated complement activation on nucleated cells. A quantitative analysis of the individual reaction steps.
Ollert MW; Kadlec JV; David K; Petrella EC; Bredehorst R; Vogel CW
J Immunol; 1994 Sep; 153(5):2213-21. PubMed ID: 8051421
[TBL] [Abstract][Full Text] [Related]
18. Solubilization of antigen-antibody complexes: a new function of complement as a regulator of immune reactions.
Takahashi M; Takahashi S; Hirose S
Prog Allergy; 1980; 27():134-66. PubMed ID: 6986046
[No Abstract] [Full Text] [Related]
19. A reexamination of the role of clusterin as a complement regulator.
Hochgrebe TT; Humphreys D; Wilson MR; Easterbrook-Smith SB
Exp Cell Res; 1999 May; 249(1):13-21. PubMed ID: 10328949
[TBL] [Abstract][Full Text] [Related]
20. Selective lysis of early embryonic cells by the alternative pathway of complement--a possible mechanism for programmed cell death in embryogenesis.
Kircheis R; Kircheis L; Oshima H; Kohchi C; Soma G; Mizuno D
In Vivo; 1996; 10(4):389-403. PubMed ID: 8839785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
